Tag Archives: Humira
By Pharm Exec | Published: July 22, 2014
AbbVie’s recent $54 billion acquisition of Shire and subsequent relocation to Ireland will mean substantial tax savings for the US pharmaceutical giant, according to analysts at research and consulting firm GlobalData.
By Ben Comer | Published: May 23, 2014
Pharm Exec’s Brand of the Year selections from the last few years are still alive and kicking, although some have aged more gracefully than others. The US drug pricing wars may be coming, but these products already made their mint. We checked back in with them to see how things are going, and to look […]
By admin | Published: August 5, 2009
On Tuesday, FDA announced that makers of tumor necrosis factor (TNF) blockers must change their labels to include boxed warnings for â€œincreased risk of lymphoma and other malignancies in children and adolescents.â€ Thatâ€™s in addition to the current box warning that the drugs might lead to cancer. TNF blockers (or inhibitors) are used to reduce […]